Felodipine in Treatment of Arterial Hypertension and Ischemic Heart Disease
Cardiovascular diseases are the leading cause of death both in the world and in the Russian Federation. The most significant contributors to the increase in mortality are arterial hypertension (AH) and ischemic heart disease (IHD). Dihydropyridine calcium channel blockers (CCBs) are the first line o...
Main Authors: | O. D. Ostroumova, I. A. Alautdinova, A. I. Kochetkov, S. N. Litvinova |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2020-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2265 |
Similar Items
-
Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction
by: Oksana Mikhaylovna Drapkina, et al.
Published: (2011-12-01) -
Construction of fluorescence system of felodipine–tetracyanovinyl–2,2′-bipyridine complex
by: Lang Yan, et al.
Published: (2023-02-01) -
Thiazide and Thiazide-like Diuretics in the Treatment of Arterial Hypertension: are there Any Differences?
by: A. I. Kochetkov
Published: (2020-12-01) -
Formulation and Characterization of Felodipine as an Oral Nanoemulsions
by: Sumaya B. Hamed, et al.
Published: (2021-06-01) -
The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
by: Liang Si-Yu, et al.
Published: (2023-09-01)